Adenosine Triphosphate
Adenosine Receptor AgonistsStructural MacromoleculesBronchoconstrictionNodal RepolarizationUS-FDASourced from openFDA
GET
/api/v1/drug/adenosine-triphosphateMechanism of action
Sourced from openFDAMechanism-of-action classes: Adenosine Receptor Agonists; Structural Macromolecules.
Adenosine Receptor
Indications
Sourced from openFDA- Directions: Turn tube upside down and rotate cap to release pellets into cap. Unscrew cap and without touching pellets tip them into the mouth under the tongue.
Dosage & administration
Sourced from openFDADIRECTIONS Take 15 minutes before meals Adults and children 12 years and older 5 pellets 3 times per day Children between 12 years and 6 years of age 3 pellets 3 times per day Children under 6 years 1 pellet 3 times per day to be dissolved into a little water
Warnings & precautions
Sourced from openFDAStop use and ask doctor if symptoms persist more than 5 days or worsen. If pregnant or breast-feeding ask a health professional before use. Keep out of reach of children.
FAERS reports
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
26 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
- 1Off Label Use415%
- 2Pneumonia415%
- 3Diarrhoea312%
- 4Acute Kidney Injury27.7%
- 5Asthenia27.7%
- 6Atrial Fibrillation27.7%
- 7Blood Culture Positive27.7%
- 8Hypocalcaemia27.7%
- 9Hyponatraemia27.7%
- 10Neuromyopathy27.7%
- 11Pain In Extremity27.7%
- 12Pancytopenia27.7%
- 13Rash27.7%
- 14Systemic Candida27.7%
- 15Acute Hepatic Failure13.8%
Literature
Recent PubMed references pinned to Adenosine Triphosphate as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- Therapeutic efficacy of glucocorticoids, ATP, and antithyroid drugs in acute thyrotoxic myopathy: evaluation using the acute thyrotoxic myopathy symptom score.Frontiers in endocrinology · 2026 · Li Q, Chen X, Huang Z, et al.PMID 42255448DOI 10.3389/fendo.2026.1769220
- Fusion Arrest and Triggered Release of Contents in Coacervates via Oxidation-Assisted Interfacial Coating.Chembiochem : a European journal of chemical biology · 2026 · Jo SA, Pak M, Jeon HG, et al.PMID 42252774DOI 10.1002/cbic.70410
- Polyphosphate synthesis is essential for phosphate and ATP homeostasis during nutrient upshift.Proceedings of the National Academy of Sciences of the United States of America · 2026 · White ML, Mortier J, Granqvist L, et al.PMID 42234530DOI 10.1073/pnas.2531128123
- Understanding chemical reactions through multimedia resolution data artistic educational tool (MRDAET).Protein science : a publication of the Protein Society · 2026 · Pokojná H, Kozlíková B, Furmanová K, et al.PMID 42231137DOI 10.1002/pro.70648
- Bivariate Cooperator-Catalyzed Hairpin Assembly for Amplifying Conformation-Guided Label-Free Ratiometric Fluorescence Biosensing.Analytical chemistry · 2026 · He M, He J, Long M, et al.PMID 42210597DOI 10.1021/acs.analchem.6c02195
- Channeling teamwork: ATP and lipids cooperate to gate P2X receptors.Science advances · 2026 · Bosmans F, Kawate TPMID 42202033DOI 10.1126/sciadv.aei2053
- ATP-responsive NIR-Ⅱ fluorescence/mass spectrometry dual-modal nanoprobe for precision diagnosis of metabolic dysfunction-associated steatohepatitis.Analytica chimica acta · 2026 · Huang F, Jing Q, Wang N, et al.PMID 42191311DOI 10.1016/j.aca.2026.345541
- Revealing mitochondrial energy/redox imbalance with a dual-channel ATP/GSH probe under conditions of epileptiform activity.Analytica chimica acta · 2026 · Wang P, Zhang H, Zhang Y, et al.PMID 42191298DOI 10.1016/j.aca.2026.345590
Clinical trials
The 10 most recently updated of 81 ClinicalTrials.gov registrations naming Adenosine Triphosphate as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell DiseaseRecruiting · Observational · 800 enrolled · National Heart, Lung, and Blood Institute (NHLBI)NCT03685721updated 2026-06-08
- Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer ProgressionRecruiting · Phase 3 · Interventional · 200 enrolled · University of UtahNCT06112990updated 2026-06-03
- Effectiveness of Audio-Tactile Performance Technique With Sing-Along Lyrics on Oral Hygiene Instruction to Visually Impaired Individuals: A Matched-Pair Randomized StudyCompleted · Interventional · 40 enrolled · Mahidol UniversityNCT07585448updated 2026-05-13
- Photobiomodulation for Episiotomies and Perineal Lacerations After Vaginal Delivery.Completed · Observational · 183 enrolled · University of Nove de JulhoNCT06893315updated 2026-04-29
- Magnetic Resonance & Optical Spectroscopy ValidationCompleted · Observational · 31 enrolled · AdventHealth Translational Research InstituteNCT01827527updated 2026-04-17
- Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility StudyRecruiting · Phase 2 · Interventional · 30 enrolled · Sunnybrook Health Sciences CentreNCT06016387updated 2026-02-23
- Evaluation of an ATP-Containing Parenteral Vitamin B Complex in Patients With Symptomatic Diabetic PolyneuropathyNot yet recruiting · Phase 4 · Interventional · 200 enrolled · Egyptian International Pharmaceutical Industries CoNCT07296354updated 2025-12-22
- Intracellular Phosphate Concentration Evolution During Hemodialysis by MR SpectroscopyCompleted · Interventional · 11 enrolled · Hospices Civils de LyonNCT03119818updated 2025-12-19
- Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)Recruiting · Phase 2 · Interventional · 121 enrolled · Priscilla Hsue, MDNCT05488431updated 2025-12-17
- Clinical Trial of TQB3002 in Patients With Advanced CancersRecruiting · Phase 1 · Interventional · 150 enrolled · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06662760updated 2025-11-25
Frequently asked questions
- How does Adenosine Triphosphate work?
- Mechanism-of-action classes: Adenosine Receptor Agonists; Structural Macromolecules.
- What is Adenosine Triphosphate used for?
- According to FDA labeling, Adenosine Triphosphate carries indications including: Directions: Turn tube upside down and rotate cap to release pellets into cap. Unscrew cap and without touching pellets tip them into the mouth under the tongue.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
- What class of drug is Adenosine Triphosphate?
- Adenosine Triphosphate is classified as Adenosine Receptor Agonists, Structural Macromolecules, Bronchoconstriction, Nodal Repolarization.
Note. Data for
adenosine-triphosphate is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.